Hebei Aipu Pharmaceutical

Hebei Aipu Pharmaceutical is a vertically integrated pharmaceutical company based in Shijiazhuang, China, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1994, the company has established a significant presence in the cardiovascular, anti-infective, and gastrointestinal therapeutic segments. Its operations are centered in the Shijiazhuang High-tech Industrial Development Zone, where it maintains GMP-compliant facilities for large-scale chemical synthesis and formulation. Hebei Aipu's product portfolio features widely used generic medications, including amlodipine besylate and enalapril maleate, which are distributed both domestically and to international markets. The company leverages its technical expertise in organic synthesis to maintain a competitive cost structure and high quality standards. As a key player in the regional pharmaceutical cluster, Hebei Aipu continues to expand its manufacturing capacity to meet global demand for essential medicines.